Chargement en cours...
Resistance Mechanisms and the Future of Bacterial Enoyl-Acyl Carrier Protein Reductase (FabI) Antibiotics
Missense mutations leading to clinical antibiotic resistance are a liability of single-target inhibitors. The enoyl-acyl carrier protein reductase (FabI) inhibitors have one intracellular protein target and drug resistance is increased by the acquisition of single-base-pair mutations that alter drug...
Enregistré dans:
| Publié dans: | Cold Spring Harb Perspect Med |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Cold Spring Harbor Laboratory Press
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772078/ https://ncbi.nlm.nih.gov/pubmed/26931811 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a027045 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|